| Global Clostridium Difficile Infection Treatment Market Growth, Forecast & Key Players |
|
| According to a newly published market research report by 24LifeSciences, global Clostridium difficile infection treatment market was valued at USD 754 million in 2024 and is projected to reach USD 1,143 million by 2031, growing at a compound annual g |
| read more |
|
|
| Microbial Mass Spectrometry Reagents Market to Grow at a CAGR of X% Through 2032 |
|
| According to a newly published market research report by 24LifeSciences, global microbial mass spectrometry reagents market was valued at USD 567.8 million in 2024 and is projected to reach USD 1.12 billion by 2032, growing at a compound annual growt |
| read more |
|
|
| Balloon Kyphoplasty Market Forecast 2026–2034: Trends & Insights |
|
| According to a newly published market research report by 24LifeSciences, global balloon kyphoplasty market was valued at USD 586.4 million in 2023 and is projected to reach USD 891.2 million by 2030, growing at a compound annual growth rate (CAGR) of |
| read more |
|
|
| Precision Cancer Therapies Market Forecast 2026–2034: Trends & Insights |
|
| According to a newly published market research report by 24LifeSciences, global precision cancer therapies market was valued at USD 12.4 billion in 2023 and is projected to reach USD 24.8 billion by 2031, growing at a compound annual growth rate (CAG |
| read more |
|
|
| Precision Cancer Therapies Market Forecast 2026–2034: Trends & Insights |
|
| According to a newly published market research report by 24LifeSciences, global precision cancer therapies market was valued at USD 12.4 billion in 2023 and is projected to reach USD 24.8 billion by 2031, growing at a compound annual growth rate (CAG |
| read more |
|
|
| Global Sleep Tracking Technologies Market Growth, Forecast & Key Players |
|
| According to a newly published market research report by 24LifeSciences, global sleep tracking technologies market was valued at USD 2.1 billion in 2024 and is projected to reach USD 5.8 billion by 2032, growing at a compound annual growth rate (CAGR |
| read more |
|
|
